Futura Medical PLC
01 July 2004
1st July 2004
Futura Medical plc
Sale of royalty rights
On 19th January 2004 Futura Medical plc ('Futura' or 'the Company'), the
AIM-listed pharmaceutical and medical device group that develops innovative
products for the sexual healthcare market, announced the settlement of an
intellectual property dispute with CST Medical Limited ('CST').
Under the settlement agreement with CST ('agreement'), certain intellectual
property was transferred to Futura together with 10 per cent of the issued share
capital of CST which has since been diluted by subsequent fundraising by CST.
In addition Futura agreed to receive a royalty in respect of sales of the Vielle
stimulator up to 31 December 2008.
On 25th June 2004 CST agreed to sell its existing Vielle operation, in respect
of United Kingdom and Republic of Ireland, to DDD Limited, the pharmaceutical,
toiletries and household brands company.
Futura now announces that, on 1st July, it agreed the sale of its royalty rights
with CST in respect of the UK and the Republic of Ireland for a one-off cash
payment of £125,000 and certain costs. Futura retains its stake in CST along
with the royalty rights on sales of the Vielle stimulator in territories outside
the United Kingdom and Republic of Ireland.
For further information:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483 685 670
mailto:james.barder@futuramedical.co.uk www.futuramedical.co.uk
Media enquiries:
Bankside
Peter Curtain / Alex Tweed Tel: +44 (0) 20 7444 4140
mailto:alexandra.tweed@bankside.com www.bankside.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.